Inspire Medical Systems, Inc. (NYSE:INSP) Receives Consensus Rating of "Hold" from Analysts

Key Points

• Analysts collectively rate Inspire Medical Systems “Hold.” Of 19 analysts, 12 issued hold ratings, three rated it a sell, three a buy and one a strong buy; the average 12-month price target is $66.50.
• Recent analyst views were mixed, with Oppenheimer upgrading the stock to “outperform” with an $85 target, while UBS initiated coverage with a “sell” rating and a $39 target.
• Inspire exceeded quarterly earnings expectations, reporting $0.14 per share versus the consensus estimate of a $0.24 loss, and revenue of $200.58 million. However, quarterly revenue declined 7.6% year over year, and analysts expect full-year earnings of about $1.24 per share.

Inspire Medical Systems, Inc. (NYSE:INSP - Get Free Report) has been given an average recommendation of "Hold" by the nineteen ratings firms that are currently covering the stock, Marketbeat.com reports. Three analysts have rated the stock with a sell rating, twelve have issued a hold rating, three have issued a buy rating and one has issued a strong buy rating on the company. The average 12 month target price among analysts that have issued ratings on the stock in the last year is $66.50.

Several research firms recently issued reports on INSP. Weiss Ratings raised Inspire Medical Systems from a "sell (d)" rating to a "sell (d+)" rating in a research report on Tuesday, September 22nd. Piper Sandler lifted their price objective on shares of Inspire Medical Systems from $55.00 to $60.00 and gave the stock a "neutral" rating in a report on Tuesday, August 4th. Oppenheimer upgraded shares of Inspire Medical Systems from a "market perform" rating to an "outperform" rating and set a $85.00 target price for the company in a research note on Tuesday, August 4th. UBS Group assumed coverage on shares of Inspire Medical Systems in a report on Tuesday, July 28th. They set a "sell" rating and a $39.00 target price on the stock. Finally, Evercore set a $54.00 price target on shares of Inspire Medical Systems in a research report on Tuesday, August 4th.

Insiders Place Their Bets

In related news, insider Jason Kelly sold 963 shares of the stock in a transaction dated Friday, August 7th. The shares were sold at an average price of $59.55, for a total transaction of $57,346.65. Following the sale, the insider owned 18,985 shares in the company, valued at $1,130,556.75. This represents a 4.83% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 2.20% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Inspire Medical Systems

Several institutional investors have recently made changes to their positions in the stock. Envestnet Portfolio Solutions Inc. acquired a new position in Inspire Medical Systems during the 2nd quarter valued at approximately $296,000. WINTON GROUP Ltd boosted its holdings in shares of Inspire Medical Systems by 790.8% during the second quarter. WINTON GROUP Ltd now owns 37,412 shares of the company's stock valued at $1,669,000 after acquiring an additional 33,212 shares during the period. Integrated Wealth Concepts LLC bought a new stake in Inspire Medical Systems in the 2nd quarter valued at about $131,000. Allworth Financial LP lifted its position in Inspire Medical Systems by 275.7% in the 2nd quarter. Allworth Financial LP now owns 1,980 shares of the company's stock valued at $88,000 after purchasing an additional 1,453 shares during the last quarter. Finally, Nykredit A S acquired a new position in Inspire Medical Systems during the 2nd quarter valued at about $78,000. 94.91% of the stock is owned by institutional investors.

Inspire Medical Systems Stock Performance

Shares of INSP stock opened at $69.59 on Thursday. Inspire Medical Systems has a one year low of $38.91 and a one year high of $147.03. The company's 50-day simple moving average is $62.67 and its 200-day simple moving average is $53.52. The stock has a market capitalization of $2.01 billion, a price-to-earnings ratio of 15.06, a PEG ratio of 5.53 and a beta of 0.70.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last announced its quarterly earnings data on Monday, August 3rd. The company reported $0.14 earnings per share for the quarter, beating the consensus estimate of ($0.24) by $0.38. The firm had revenue of $200.58 million during the quarter, compared to analyst estimates of $194.72 million. Inspire Medical Systems had a return on equity of 8.64% and a net margin of 15.03%.Inspire Medical Systems's quarterly revenue was down 7.6% on a year-over-year basis. During the same period in the previous year, the company earned $0.45 earnings per share. Inspire Medical Systems has set its FY 2026 guidance at 1.050-1.450 EPS. As a group, research analysts forecast that Inspire Medical Systems will post 1.24 EPS for the current year.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc develops and commercializes medical devices for treating moderate to severe obstructive sleep apnea (OSA), a condition in which the upper airway repeatedly becomes blocked during sleep. The company's primary product is Inspire therapy, an implantable system designed for patients who are unable to use or obtain consistent benefit from continuous positive airway pressure (CPAP) therapy.

The Inspire system uses a small implantable pulse generator, a breathing-sensing lead and a stimulation lead.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.